In vivo antitumor activity of NVP-AEW541-A novel, potent, and selective inhibitor of the IGF-IR kinase (Q42799629)

7 November 2017

title

In vivo antitumor activity of NVP-AEW541-A novel, potent, and selective inhibitor of the IGF-IR kinase (English)

1 reference

7 November 2017

0 references

Carlos García-Echeverría

1

1 reference

7 November 2017

Mark A Pearson

2

1 reference

7 November 2017

Andreas Marti

3

1 reference

7 November 2017

Thomas Meyer

4

1 reference

7 November 2017

Juergen Mestan

5

1 reference

7 November 2017

Johann Zimmermann

6

1 reference

7 November 2017

Jiaping Gao

7

1 reference

7 November 2017

Josef Brueggen

8

1 reference

7 November 2017

Hans-Georg Capraro

9

1 reference

7 November 2017

Robert Cozens

10

1 reference

7 November 2017

Dean B Evans

11

1 reference

7 November 2017

Doriano Fabbro

12

1 reference

7 November 2017

Pascal Furet

13

1 reference

7 November 2017

Diana Graus Porta

14

1 reference

7 November 2017

Janis Liebetanz

15

1 reference

7 November 2017

Georg Martiny-Baron

16

1 reference

7 November 2017

Stephan Ruetz

17

1 reference

7 November 2017

Francesco Hofmann

18

1 reference

7 November 2017

publication date

1 March 2004

1 reference

7 November 2017

1 reference

7 November 2017

volume

5

1 reference

7 November 2017

issue

3

1 reference

7 November 2017

page(s)

231-239

1 reference

describes a project that uses

7 November 2017

NWT-21

0 references

cites work

Molecular basis for the substrate specificity of protein kinase B; comparison with MAPKAP kinase-1 and p70 S6 kinase

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900051-0

7 January 2021

cdc2 is a component of the M phase-specific histone H1 kinase: evidence for identity with MPF

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900051-0

7 January 2021

Interaction between the cell-cycle-control proteins p34cdc2 and p9CKShs2. Evidence for two cooperative binding domains in p9CKShs2

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900051-0

7 January 2021

The contradictions of the insulin-like growth factor 1 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900051-0

7 January 2021

Bcr/Abl expression stimulates integrin function in hematopoietic cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900051-0

7 January 2021

Interactions of CBL with BCR-ABL and CRKL in BCR-ABL-transformed myeloid cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900051-0

7 January 2021

Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900051-0

7 January 2021

Treatment of human breast cancer cells with antisense RNA to the type I insulin-like growth factor receptor inhibits cell growth, suppresses tumorigenesis, alters the metastatic potential, and prolongs survival in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900051-0

7 January 2021

A functional insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900051-0

7 January 2021

Insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the platelet-derived growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900051-0

7 January 2021

Effects of insulin-like growth factors (IGFs) and IGF receptor antibodies on the proliferation of human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900051-0

7 January 2021

Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900051-0

7 January 2021

Insulin-like growth factors and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900051-0

7 January 2021

Activation of protein kinase C subtypes alpha, gamma, delta, epsilon, zeta, and eta by tumor-promoting and nontumor-promoting agents

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900051-0

7 January 2021

Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900051-0

7 January 2021

Expression of a kinase-deficient IGF-I-R suppresses tumorigenicity of rhabdomyosarcoma cells constitutively expressing a wild type IGF-I-R

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900051-0

7 January 2021

Overexpression of the human insulinlike growth factor I receptor promotes ligand-dependent neoplastic transformation

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900051-0

7 January 2021

The effects of insulin-like growth factors on tumorigenesis and neoplastic growth

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900051-0

7 January 2021

Elevated levels of IGF-1 receptor convey invasive and metastatic capability in a mouse model of pancreatic islet tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900051-0

7 January 2021

Large-scale purification and characterisation of a recombinant epidermal growth-factor receptor protein-tyrosine kinase. Modulation of activity by multiple factors

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900051-0

7 January 2021

Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900051-0

7 January 2021

Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor I receptor mutant

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900051-0

7 January 2021

Involvement of Shc in insulin- and epidermal growth factor-induced activation of p21ras

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900051-0

7 January 2021

Inhibition of Carcinoma Cell Growth and Metastasis by a Vesicular Stomatitis Virus G-Pseudotyped Retrovector Expressing Type I Insulin-Like Growth Factor Receptor Antisense

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900051-0

7 January 2021

Expression of an IGF-I receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900051-0

7 January 2021

Effectiveness of insulin-like growth factor I receptor antisense strategy against Ewing's sarcoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900051-0

7 January 2021

Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900051-0

7 January 2021

Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900051-0

7 January 2021

Antisense-mediated reduction in insulin-like growth factor-I receptor expression suppresses the malignant phenotype of a human alveolar rhabdomyosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900051-0

7 January 2021

Expression of protein kinase C isotypes using baculovirus vectors.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900051-0

7 January 2021

Dual control of cell growth by somatomedins and platelet-derived growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900051-0

7 January 2021

Signal transduction by receptors with tyrosine kinase activity

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900051-0

7 January 2021

Insulin-like growth factor I receptor signaling in transformation by src oncogenes

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900051-0

7 January 2021

Insulin-like growth factor receptor-1 as an anti-cancer target: blocking transformation and inducing apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900051-0

7 January 2021

Antisense inhibition of IGF receptor expression in HaCaT keratinocytes: a model for antisense strategies in keratinocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900051-0

7 January 2021

Both p21ras and pp60v-src are required, but neither alone is sufficient, to activate the Raf-1 kinase

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900051-0

7 January 2021

Role of the insulin-like growth factor family in cancer development and progression

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2804%2900051-0

7 January 2021

10.1016/S1535-6108(04)00051-0

Identifiers

DOI

1 reference

release_nsjho2zxmfherjkgunxblua42e

7 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nsjho2zxmfherjkgunxblua42e

24 November 2022

mapped directly with Wikidata item

1 reference